Multidrug	O
Resistance	O
of	O
Acinetobacter	B:C0314787
Baumannii	I:C0314787
in	O
Ladoke	O
Akintola	I:C0019994
University	I:C0019994
Teaching	I:C0019994
Hospital	I:C0019994
,	O
Osogbo	O
,	I:C0028075
Nigeria	I:C0028075
.	O

Multidrug	O
Resistance	O
of	O
Acinetobacter	O
Baumannii	I:C0314787
in	O
Ladoke	B:C0019994
Akintola	I:C0019994
University	I:C0019994
Teaching	I:C0019994
Hospital	I:C0019994
,	O
Osogbo	O
,	I:C0028075
Nigeria	I:C0028075
.	O

Multidrug	O
Resistance	O
of	O
Acinetobacter	O
Baumannii	I:C0314787
in	O
Ladoke	O
Akintola	I:C0019994
University	I:C0019994
Teaching	I:C0019994
Hospital	I:C0019994
,	O
Osogbo	B:C0028075
,	I:C0028075
Nigeria	I:C0028075
.	O

Acinetobacter	B:C0314787
baumannii	I:C0314787
is	O
a	O
ubiquitous	O
pathogen	O
that	O
has	O
emerged	O
as	O
a	O
major	O
cause	O
of	O
healthcare	O
-	I:C0010356
associated	I:C0010356
infections	I:C0010356
at	O
Ladoke	O
Akintola	I:C0019994
University	I:C0019994
Teaching	I:C0019994
Hospital	I:C0019994
.	O

Acinetobacter	O
baumannii	I:C0314787
is	O
a	O
ubiquitous	O
pathogen	O
that	O
has	O
emerged	O
as	O
a	O
major	O
cause	O
of	O
healthcare	B:C0010356
-	I:C0010356
associated	I:C0010356
infections	I:C0010356
at	O
Ladoke	O
Akintola	I:C0019994
University	I:C0019994
Teaching	I:C0019994
Hospital	I:C0019994
.	O

Acinetobacter	O
baumannii	I:C0314787
is	O
a	O
ubiquitous	O
pathogen	O
that	O
has	O
emerged	O
as	O
a	O
major	O
cause	O
of	O
healthcare	O
-	I:C0010356
associated	I:C0010356
infections	I:C0010356
at	O
Ladoke	B:C0019994
Akintola	I:C0019994
University	I:C0019994
Teaching	I:C0019994
Hospital	I:C0019994
.	O

Isolates	B:C3494793
were	O
assayed	O
according	O
to	O
standard	O
protocol	I:C0442711
.	O

Isolates	O
were	O
assayed	B:C1510438
according	O
to	O
standard	O
protocol	I:C0442711
.	O

Isolates	O
were	O
assayed	O
according	O
to	O
standard	B:C0442711
protocol	I:C0442711
.	O

The	O
isolates	B:C3494793
were	O
subjected	O
to	O
molecular	O
techniques	I:C1513384
to	O
detect	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
blaCTX-M	I:C1442492
,	I:C1442492
and	I:C1442492
blaSHV	I:C1442492
genes	I:C1442492
in	O
strains	O
of	O
the	O
A.	O
baumannii	I:C0314787
isolates	O
.	O

The	O
isolates	O
were	O
subjected	O
to	O
molecular	B:C1513384
techniques	I:C1513384
to	O
detect	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
blaCTX-M	I:C1442492
,	I:C1442492
and	I:C1442492
blaSHV	I:C1442492
genes	I:C1442492
in	O
strains	O
of	O
the	O
A.	O
baumannii	I:C0314787
isolates	O
.	O

The	O
isolates	O
were	O
subjected	O
to	O
molecular	O
techniques	I:C1513384
to	O
detect	O
blaOXA	B:C1442492
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
blaCTX-M	I:C1442492
,	I:C1442492
and	I:C1442492
blaSHV	I:C1442492
genes	I:C1442492
in	O
strains	O
of	O
the	O
A.	O
baumannii	I:C0314787
isolates	O
.	O

The	O
isolates	O
were	O
subjected	O
to	O
molecular	O
techniques	I:C1513384
to	O
detect	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
blaCTX-M	I:C1442492
,	I:C1442492
and	I:C1442492
blaSHV	I:C1442492
genes	I:C1442492
in	O
strains	B:C0314787
of	O
the	O
A.	O
baumannii	I:C0314787
isolates	O
.	O

The	O
isolates	O
were	O
subjected	O
to	O
molecular	O
techniques	I:C1513384
to	O
detect	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
blaCTX-M	I:C1442492
,	I:C1442492
and	I:C1442492
blaSHV	I:C1442492
genes	I:C1442492
in	O
strains	O
of	O
the	O
A.	B:C0314787
baumannii	I:C0314787
isolates	O
.	O

The	O
isolates	O
were	O
subjected	O
to	O
molecular	O
techniques	I:C1513384
to	O
detect	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
blaCTX-M	I:C1442492
,	I:C1442492
and	I:C1442492
blaSHV	I:C1442492
genes	I:C1442492
in	O
strains	O
of	O
the	O
A.	O
baumannii	I:C0314787
isolates	B:C3494793
.	O

The	O
prevalence	O
of	O
A.	B:C0314787
baumannii	I:C0314787
was	O
8.5	O
%	O
and	O
was	O
most	O
prevalent	O
among	O
patients	O
in	O
the	O
age	O
group	O
51	O
-	O
60	O
(	O
36	O
%	O
)	O
;	O
the	O
male	O
patients	O
(	O
63.6	O
%	O
)	O
were	O
more	O
infected	O
than	O
their	O
female	O
counterparts	O
.	O

The	O
prevalence	O
of	O
A.	O
baumannii	I:C0314787
was	O
8.5	O
%	O
and	O
was	O
most	O
prevalent	O
among	O
patients	O
in	O
the	O
age	O
group	O
51	O
-	O
60	O
(	O
36	O
%	O
)	O
;	O
the	O
male	O
patients	O
(	O
63.6	O
%	O
)	O
were	O
more	O
infected	B:C0439663
than	O
their	O
female	O
counterparts	O
.	O

Patients	O
(	O
72.7	O
%	O
)	O
in	O
the	O
intensive	B:C0021708
care	I:C0021708
unit	I:C0021708
(	O
intensive	O
care	I:C0021708
unit	I:C0021708
)	O
were	O
most	O
infected	O
with	O
this	O
organism	O
.	O

Patients	O
(	O
72.7	O
%	O
)	O
in	O
the	O
intensive	O
care	I:C0021708
unit	I:C0021708
(	O
intensive	B:C0021708
care	I:C0021708
unit	I:C0021708
)	O
were	O
most	O
infected	O
with	O
this	O
organism	O
.	O

Patients	O
(	O
72.7	O
%	O
)	O
in	O
the	O
intensive	O
care	I:C0021708
unit	I:C0021708
(	O
intensive	O
care	I:C0021708
unit	I:C0021708
)	O
were	O
most	O
infected	B:C0439663
with	O
this	O
organism	O
.	O

The	O
isolates	B:C3494793
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	O
and	O
ciprofloxacin	O
and	O
90.9	O
%	O
to	O
both	O
ceftriaxone	O
and	O
ceftazidime	O
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	O
used	O
in	O
this	O
study	O
were	O
:	O
piperacillin	O
(	O
81.8	O
%	O
)	O
,	O
imipenem	O
(	O
72.7	O
%	O
)	O
,	O
gentamycin	O
(	O
72.2	O
%	O
)	O
,	O
and	O
meropenem	O
(	O
63.6	O
%	O
)	O
.	O

The	O
isolates	O
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	B:C0002499
and	O
ciprofloxacin	O
and	O
90.9	O
%	O
to	O
both	O
ceftriaxone	O
and	O
ceftazidime	O
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	O
used	O
in	O
this	O
study	O
were	O
:	O
piperacillin	O
(	O
81.8	O
%	O
)	O
,	O
imipenem	O
(	O
72.7	O
%	O
)	O
,	O
gentamycin	O
(	O
72.2	O
%	O
)	O
,	O
and	O
meropenem	O
(	O
63.6	O
%	O
)	O
.	O

The	O
isolates	O
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	O
and	O
ciprofloxacin	B:C0008809
and	O
90.9	O
%	O
to	O
both	O
ceftriaxone	O
and	O
ceftazidime	O
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	O
used	O
in	O
this	O
study	O
were	O
:	O
piperacillin	O
(	O
81.8	O
%	O
)	O
,	O
imipenem	O
(	O
72.7	O
%	O
)	O
,	O
gentamycin	O
(	O
72.2	O
%	O
)	O
,	O
and	O
meropenem	O
(	O
63.6	O
%	O
)	O
.	O

The	O
isolates	O
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	O
and	O
ciprofloxacin	O
and	O
90.9	O
%	O
to	O
both	O
ceftriaxone	B:C0007561
and	O
ceftazidime	O
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	O
used	O
in	O
this	O
study	O
were	O
:	O
piperacillin	O
(	O
81.8	O
%	O
)	O
,	O
imipenem	O
(	O
72.7	O
%	O
)	O
,	O
gentamycin	O
(	O
72.2	O
%	O
)	O
,	O
and	O
meropenem	O
(	O
63.6	O
%	O
)	O
.	O

The	O
isolates	O
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	O
and	O
ciprofloxacin	O
and	O
90.9	O
%	O
to	O
both	O
ceftriaxone	O
and	O
ceftazidime	B:C0007559
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	O
used	O
in	O
this	O
study	O
were	O
:	O
piperacillin	O
(	O
81.8	O
%	O
)	O
,	O
imipenem	O
(	O
72.7	O
%	O
)	O
,	O
gentamycin	O
(	O
72.2	O
%	O
)	O
,	O
and	O
meropenem	O
(	O
63.6	O
%	O
)	O
.	O

The	O
isolates	O
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	O
and	O
ciprofloxacin	O
and	O
90.9	O
%	O
to	O
both	O
ceftriaxone	O
and	O
ceftazidime	O
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	B:C0003232
used	O
in	O
this	O
study	O
were	O
:	O
piperacillin	O
(	O
81.8	O
%	O
)	O
,	O
imipenem	O
(	O
72.7	O
%	O
)	O
,	O
gentamycin	O
(	O
72.2	O
%	O
)	O
,	O
and	O
meropenem	O
(	O
63.6	O
%	O
)	O
.	O

The	O
isolates	O
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	O
and	O
ciprofloxacin	O
and	O
90.9	O
%	O
to	O
both	O
ceftriaxone	O
and	O
ceftazidime	O
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	O
used	O
in	O
this	O
study	B:C2603343
were	O
:	O
piperacillin	O
(	O
81.8	O
%	O
)	O
,	O
imipenem	O
(	O
72.7	O
%	O
)	O
,	O
gentamycin	O
(	O
72.2	O
%	O
)	O
,	O
and	O
meropenem	O
(	O
63.6	O
%	O
)	O
.	O

The	O
isolates	O
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	O
and	O
ciprofloxacin	O
and	O
90.9	O
%	O
to	O
both	O
ceftriaxone	O
and	O
ceftazidime	O
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	O
used	O
in	O
this	O
study	O
were	O
:	O
piperacillin	B:C0031955
(	O
81.8	O
%	O
)	O
,	O
imipenem	O
(	O
72.7	O
%	O
)	O
,	O
gentamycin	O
(	O
72.2	O
%	O
)	O
,	O
and	O
meropenem	O
(	O
63.6	O
%	O
)	O
.	O

The	O
isolates	O
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	O
and	O
ciprofloxacin	O
and	O
90.9	O
%	O
to	O
both	O
ceftriaxone	O
and	O
ceftazidime	O
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	O
used	O
in	O
this	O
study	O
were	O
:	O
piperacillin	O
(	O
81.8	O
%	O
)	O
,	O
imipenem	B:C0066005
(	O
72.7	O
%	O
)	O
,	O
gentamycin	O
(	O
72.2	O
%	O
)	O
,	O
and	O
meropenem	O
(	O
63.6	O
%	O
)	O
.	O

The	O
isolates	O
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	O
and	O
ciprofloxacin	O
and	O
90.9	O
%	O
to	O
both	O
ceftriaxone	O
and	O
ceftazidime	O
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	O
used	O
in	O
this	O
study	O
were	O
:	O
piperacillin	O
(	O
81.8	O
%	O
)	O
,	O
imipenem	O
(	O
72.7	O
%	O
)	O
,	O
gentamycin	B:C3854019
(	O
72.2	O
%	O
)	O
,	O
and	O
meropenem	O
(	O
63.6	O
%	O
)	O
.	O

The	O
isolates	O
showed	O
100	O
%	O
resistance	O
to	O
both	O
amikacin	O
and	O
ciprofloxacin	O
and	O
90.9	O
%	O
to	O
both	O
ceftriaxone	O
and	O
ceftazidime	O
,	O
while	O
resistance	O
to	O
the	O
other	O
antibiotics	O
used	O
in	O
this	O
study	O
were	O
:	O
piperacillin	O
(	O
81.8	O
%	O
)	O
,	O
imipenem	O
(	O
72.7	O
%	O
)	O
,	O
gentamycin	O
(	O
72.2	O
%	O
)	O
,	O
and	O
meropenem	B:C0066005
(	O
63.6	O
%	O
)	O
.	O

None	O
of	O
the	O
isolates	B:C3494793
was	O
,	O
however	O
,	O
resistant	O
to	O
colistin	O
.	O

None	O
of	O
the	O
isolates	O
was	O
,	O
however	O
,	O
resistant	O
to	O
colistin	B:C0002499
.	O

PCR	B:C0032520
results	O
showed	O
that	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
and	I:C1442492
blaCTX	I:C1442492
-	I:C1442492
M	I:C1442492
genes	I:C1442492
were	O
positive	O
in	O
some	O
isolates	O
,	O
while	O
blaSHV	O
was	O
not	O
detected	I:C0442737
in	O
any	O
of	O
the	O
isolates	O
.	O

PCR	O
results	B:C0456984
showed	O
that	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
and	I:C1442492
blaCTX	I:C1442492
-	I:C1442492
M	I:C1442492
genes	I:C1442492
were	O
positive	O
in	O
some	O
isolates	O
,	O
while	O
blaSHV	O
was	O
not	O
detected	I:C0442737
in	O
any	O
of	O
the	O
isolates	O
.	O

PCR	O
results	O
showed	O
that	O
blaOXA	B:C1442492
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
and	I:C1442492
blaCTX	I:C1442492
-	I:C1442492
M	I:C1442492
genes	I:C1442492
were	O
positive	O
in	O
some	O
isolates	O
,	O
while	O
blaSHV	O
was	O
not	O
detected	I:C0442737
in	O
any	O
of	O
the	O
isolates	O
.	O

PCR	O
results	O
showed	O
that	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
and	I:C1442492
blaCTX	I:C1442492
-	I:C1442492
M	I:C1442492
genes	I:C1442492
were	O
positive	B:C1446409
in	O
some	O
isolates	O
,	O
while	O
blaSHV	O
was	O
not	O
detected	I:C0442737
in	O
any	O
of	O
the	O
isolates	O
.	O

PCR	O
results	O
showed	O
that	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
and	I:C1442492
blaCTX	I:C1442492
-	I:C1442492
M	I:C1442492
genes	I:C1442492
were	O
positive	O
in	O
some	O
isolates	B:C3494793
,	O
while	O
blaSHV	O
was	O
not	O
detected	I:C0442737
in	O
any	O
of	O
the	O
isolates	O
.	O

PCR	O
results	O
showed	O
that	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
and	I:C1442492
blaCTX	I:C1442492
-	I:C1442492
M	I:C1442492
genes	I:C1442492
were	O
positive	O
in	O
some	O
isolates	O
,	O
while	O
blaSHV	B:C1442492
was	O
not	O
detected	I:C0442737
in	O
any	O
of	O
the	O
isolates	O
.	O

PCR	O
results	O
showed	O
that	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
and	I:C1442492
blaCTX	I:C1442492
-	I:C1442492
M	I:C1442492
genes	I:C1442492
were	O
positive	O
in	O
some	O
isolates	O
,	O
while	O
blaSHV	O
was	O
not	B:C0442737
detected	I:C0442737
in	O
any	O
of	O
the	O
isolates	O
.	O

PCR	O
results	O
showed	O
that	O
blaOXA	O
,	I:C1442492
blaTEM	I:C1442492
,	I:C1442492
and	I:C1442492
blaCTX	I:C1442492
-	I:C1442492
M	I:C1442492
genes	I:C1442492
were	O
positive	O
in	O
some	O
isolates	O
,	O
while	O
blaSHV	O
was	O
not	O
detected	I:C0442737
in	O
any	O
of	O
the	O
isolates	B:C3494793
.	O

This	O
study	B:C2603343
has	O
revealed	O
that	O
the	O
strains	O
of	O
A.	O
baumannii	I:C0314787
isolated	O
are	O
multiple	O
drug	O
resistant	O
.	O

This	O
study	O
has	O
revealed	O
that	O
the	O
strains	B:C0314787
of	O
A.	O
baumannii	I:C0314787
isolated	O
are	O
multiple	O
drug	O
resistant	O
.	O

This	O
study	O
has	O
revealed	O
that	O
the	O
strains	O
of	O
A.	B:C0314787
baumannii	I:C0314787
isolated	O
are	O
multiple	O
drug	O
resistant	O
.	O

Regular	O
monitoring	B:C1283169
,	O
judicious	O
prescription	O
,	O
and	O
early	O
detection	O
of	O
resistance	O
to	O
these	O
antibiotics	O
are	O
,	O
therefore	O
,	O
necessary	O
to	O
check	O
further	O
dissemination	O
of	O
the	O
organism	O
.	O

Regular	O
monitoring	O
,	O
judicious	O
prescription	B:C0033080
,	O
and	O
early	O
detection	O
of	O
resistance	O
to	O
these	O
antibiotics	O
are	O
,	O
therefore	O
,	O
necessary	O
to	O
check	O
further	O
dissemination	O
of	O
the	O
organism	O
.	O

Regular	O
monitoring	O
,	O
judicious	O
prescription	O
,	O
and	O
early	O
detection	B:C1511790
of	O
resistance	O
to	O
these	O
antibiotics	O
are	O
,	O
therefore	O
,	O
necessary	O
to	O
check	O
further	O
dissemination	O
of	O
the	O
organism	O
.	O

Regular	O
monitoring	O
,	O
judicious	O
prescription	O
,	O
and	O
early	O
detection	O
of	O
resistance	O
to	O
these	O
antibiotics	B:C0003232
are	O
,	O
therefore	O
,	O
necessary	O
to	O
check	O
further	O
dissemination	O
of	O
the	O
organism	O
.	O

